100% of the funds you raise will go to cancer research through the Velocity Fellows and COVID-19 recovery efforts at Columbia’s Cancer Center.
THE TIME IS NOW
COVID-19 has impacted the world, our country and New York City in ways we could not have imagined. Doctors, nurses, faculty and staff at Columbia University Irving Medical Center are on the front lines, taking extraordinary measures with dedication to care for their patients and the community they serve.
Columbia’s Herbert Irving Comprehensive Cancer Center (HICCC) is one of 49 National Cancer Institute (NCI) designated Comprehensive Cancer Centers nationwide, recognizing scientific and clinical excellence, and one of only two in New York City. With close to 3,500 new cancer cases seen each year, the HICCC delivers cutting-edge cancer research and patient care. At Columbia, we don’t just practice medicine, we change it. HICCC researchers are at the forefront of pioneering the latest approaches to cancer treatment like immunotherapy and precision medicine.
COVID-19 & HICCC
This year, the funds raised through Your Velocity will go directly to cancer research and the HICCC COVID-19 Relief Fund. This fund will provide immediate support to our frontline caregivers and patients through a variety of important programs, including:
* Mental health support groups for doctors, nurses, and staff members,
* Transportation funds for those hospital staff who can’t take public transportation
* Increased screening and education efforts for early detection
* Telehealth optimization for safer patient appointments, and
* Community support programs which ensure that recently discharged patients receive follow-up support and safety guidelines from medical and nurse practitioner students.
In addition to providing unrestricted funds to the HICCC COVID-19 Relief Fund, Velocity will continue to support our Velocity Fellows - a program that brings crucial funds to early stage cancer research. We're excited to announce that four new Columbia cancer researchers have been awarded Velocity seed funding. Click below to learn more about their research.